Concepedia

Bethany L. Mundy-Bosse

BL

Statistics

Publications

40

Citations

3.2K

H-Index

28

Active since

2001

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Nationwide Children's Hospital

City Of Hope National Medical Center

The Ohio State University Wexner Medical Center

Bethany L. Mundy-Bosse is an author at The Ohio State University specializing in life sciences, oncology, and immunology.

ORCID

Publications per year

2001–2025

40

Publications

40

Ibrutinib treatment improves T cell number and function in CLL patients

Meixiao Long, Kyle A. Beckwith, Priscilla Do et al. · Journal of Clinical Investigation · 2017 · 377 citations · Full text

, , +17

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Andrew Stiff, Prashant Trikha, Bethany L. Mundy-Bosse et al. · Clinical Cancer Research · 2018 · 236 citations · Full text

, , +17

A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets

Steven D. Scoville, Bethany L. Mundy-Bosse, Michael H. Zhang et al. · Immunity · 2016 · 193 citations · Full text

, , +10

Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice

Bethany L. Mundy-Bosse, Gregory B. Lesinski, Alena Cristina Jaime‐Ramirez et al. · Cancer Research · 2011 · 188 citations · Full text

, , +17

Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia

I-K Park, Bethany L. Mundy-Bosse, Susan P. Whitman et al. · Leukemia · 2015 · 164 citations · Full text

, , +17

1–5 of 40